The effects of isoproterenol were examined in 10 conscious, chronically instrumented adult dogs with left ventricular (LV) failure after pressure overload hypertrophy induced by aortic banding at 8-10 weeks of age (LV free wall plus septum-to-body weight ratio, 8.6±f.0.5 g/kg) and also in eight control dogs (LV free wall plus septum-to-body weight ratio, 5.1±0.3 g/kg). Baseline values of heart rate, LV end-diastolic pressure, LV end-diastolic stress, and LV systolic wall stress were greater in the LV failure dogs (p<0.01), whereas the ejection phase index, rate of change of LV short-axis diameter, LV dD/dt, was depressed compared with control animals. In the control animals, isoproterenol infusion increased Vcf and LV dD/dt significantly (p<0.05), whereas LV systolic wall stress did not change. In the LV failure dogs, the increases in Vcf and LV dD/dt were less (p<0.01), and LV systolic wall stress increased (p<0.01). In the control animals, LV end-diastolic pressure, LV end-diastolic stress, LV end-diastolic stressdimension ratio, diastolic radial myocardial stiffness, and the time constant of isovolumic relaxation decreased (p<0.05), whereas in the LV failure dogs, LV end-diastolic pressure, LV end-diastolic stress, diastolic radial myocardial stiffness, and the LV end-diastolic stressdimension ratio increased. In the LV failure group, the endocardial to epicardial blood flow ratio fell to 0.59±0.06 during isoproterenol infusion, that is, significantly lower than in control dogs (0.93+±0.06). These data support the concept that potent sympathomimetic amines exert deleterious effects on systolic and diastolic function in the failing heart, potentially related to subendocardial hypoperfusion. (Circulation 1989;80:658-668) L eft ventricular (LV) failure is generally characterized by elevated circulating levels and reduced myocardial stores of catecholamines and by reduced responsiveness to infusions of sympathomimetic amines. [1] [2] [3] [4] [5] [6] [7] In fact, /3-adrenergic blockers have been suggested as one potential therapeutic intervention in patients with LV failure.8'9 The mechanism for the lack of efficacy of potent sympa-From the thomimetic amines remains controversial. One mechanism, which has been postulated, involves alterations in either /3-adrenergic receptor density10 or /3-adrenergic receptor coupling.11'12 Also, in certain models of LV hypertrophy and failure, for example, severe pressure overload, relative subendocardial ischemia may be involved in the mechanism of depressed functional response to sympathomimetic amines.
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The purpose of this study was to determine the responses of LV systolic and diastolic function to an inotropic and chronotropic stress induced by isoproterenol in conscious dogs with pressure overload LV hypertrophy and failure. A second goal was to determine whether or not these alterations in myocardial function were associated with alterations in transmural myocardial blood flow. These studies were conducted in conscious dogs in the absence of the complicating effects of general anesthesia and recent surgery.13
Methods

Development of Model
Mongrel puppies of either sex at 8-10 weeks of age were anesthetized with sodium thiamylal, 12.5 mg/kg, maintained with halothane (1 vol%), and ventilated with a respirator (Harvard Apparatus, S. Natick, Massachusetts). A right thoracotomy was performed through the fourth intercostal space using sterile surgical technique. The ascending aorta above the coronary arteries was isolated and dissected free of surrounding tissue. A 1 cm wide Teflon cuff was placed around the aorta, tightened until a thrill could be palpated over the aortic arch, and the chest was closed. The Teflon band created a fixed supravalvular aortic lesion, which became relatively more stenotic as the puppies grew. At maturity, five dogs spontaneously developed LV congestive failure. Evidence of congestive failure included at least one episode of pulmonary edema defined by intense dyspnea and LV end-diastolic pressure greater than 30 mm Hg and by evidence of pulmonary congestion at autopsy. In five dogs with severe pressure overload LV hypertrophy, but without spontaneous heart failure, heart failure was induced by superimposition of a volume overload lesion. After general anesthesia with sodium thiamylal followed by halothane, a 1.5 cm wide side-to-side bilateral iliac arteriovenous anastomosis was created using sterile surgical technique. The dogs were monitored daily and allowed to recover for at least 2 weeks after this procedure. Implantation of Instrumentation At 9 to 17 months of age, 10 aortic-banded dogs, five additional nonbanded littermates, and three mongrel dogs were instrumented. After general anesthesia with sodium thiamylal, an incision was made in the fifth left intercostal space, using sterile surgical technique and halothane (0.5-2.0 vol%) anesthesia. Tygon catheters (Norton Elastics and Synthetic Division, Akron, Ohio) were implanted in the descending thoracic aorta, in the left atrium in all dogs, and in the LV apex of banded dogs. In eight aortic-banded dogs and eight control dogs, piezoelectric ultrasonic dimension crystals were implanted on opposing anterior and posterior endocardial surfaces of the LV to measure the short-axis internal diameter. Wall thickness was measured in eight aortic-banded dogs and eight control dogs by implanting piezoelectric ultrasonic dimension crystals on opposing endocardial and epicardial surfaces in the same plane as the internal diameter crystals. It was not feasible to implant ultrasonic crystals in two of the dogs with heart failure. A solid-state miniature pressure transducer (Model P22, Konigsberg Instruments, Pasadena, California) was implanted in the apex to measure LV pressure in seven aortic-banded dogs and eight control dogs. The thoracotomy incision was closed in layers, and the animals were allowed to recover for 2-3 weeks before study. The animals used in this study were maintained in accordance with the guidelines for the "Care and Use of Laboratory Animals" of the Institute of Laboratory Animal Resources, National Council (DHHS publication No.
[NIH] 85-23 revised 1985).
Experimental Measurements
Statham strain-gauge manometers (Models P23 ID Statham Instruments, Oxnard, California) connected to the chronically implanted catheters were calibrated with a mercury manometer and used to measure aortic and LV pressures. LV pressure was measured using the solid-state miniature pressure gauge calibrated in vitro with a mercury manometer and in vivo with the LV catheter and Statham strain-gauge manometer.14,15 LV internal diameter and wall thickness were measured using an ultrasonic transit-time dimension gauge.16 Any drift in the measurement system was eliminated during the experiment by periodic calibration accomplished by substituting impulses of known duration from a crystal-controlled pulse generator. The position of all transducers was confirmed at autopsy.
After initial experiments indicated differences in responses of LV function to isoproterenol, myocardial blood flow was measured in subsequent experiments. Regional myocardial blood flow was measured with isotopically labeled microspheres (15 +2 gm in diameter, New England Nuclear, Boston, Massachusetts) in six control dogs and five dogs with LV failure at baseline and in response to isoproterenol, 0.4 ,ug/kg/min. The radioactive label of the microspheres (141Ce, 113Snn 114In, 51Cr, 103Ru, 95Nb, 85Sr, or 46Sc) was chosen randomly. The microspheres were suspended in 0.01% Tween 80 solution (10% dextran) agitated by direct application of an ultrasonic probe to ensure dispersion of the microspheres and placed in an ultrasonic bath for at least 30 minutes before injection. Before injection of microspheres, 0.7 ml Tween 80 dextran solution (without microspheres) was injected to determine whether or not the diluent for the microsphere suspension would have an adverse effect on measurement of cardiac or systemic hemodynamics. One to two million microspheres were injected through the catheter implanted in the left atrium for determination of blood flow. A reference sample of arterial blood was withdrawn (7.75 ml/min) from the catheter in the descending aorta. Reference sample withdrawal was initiated 15 seconds before microsphere injection and continued for approximately 90 seconds after the injection was completed (total withdrawal time was 120 seconds). After the animals were killed with a lethal dose of sodium pentobarbital (50 mg/kg), the atria and the right ventricular (RV) free wall were removed and weighed. The LV free wall plus septum was also weighed. Samples of myocardial tissue from the LV free walls were subdivided into four equal transmural layers from epicardium to endocardium, weighed, and placed in a gamma counter (Canberra, Meriden, Connecticut) with appropriately selected energy windows. The raw counts were corrected for background and crossover and compared with the reference blood sample to obtain flow expressed in milliliters per minute per gram of tissue. Endocardial/ epicardial blood flow ratios were obtained by dividing blood flow in the endocardial layer by the epicardial layer. In the control dogs, mean aortic pressure was used to assess coronary perfusion pressure. In the dogs with LV hypertrophy and failure, mean coronary perfusion pressure was computed with the technique described by Bache et al. 17 
Experimental Protocol
Experiments were performed in a quiet laboratory with the unsedated, conscious dogs resting comfortably in the right lateral position. Isoproterenol (Isuprel hydrochloride, Winthrop Breon, New York) was infused intravenously at different doses (5 minutes at 0.025, 0.05, 0.1, 0.2, and 0.4 ,ug/ kg/min) in 10 dogs with heart failure and eight control dogs. After control hemodynamic measurements, radioactive microspheres were injected in five dogs with heart failure and six control dogs for measurement of regional myocardial blood flow. Radioactive microspheres were also injected for measurement of regional blood flow during the infusion of isoproterenol at the dose of 0.4 ,ug/ kg/min after all the parameters measured had achieved a new steady-state level (approximately 5 minutes). Because isoproterenol altered LV enddiastolic pressure, the effects of controlled volume loading and hemorrhage were examined in four of the control dogs to study the effects of small changes in preload on indexes of diastolic function.
Data Analysis
The data were recorded on a multichannel tape recorder (Model 101, Honeywell, Denver, Colorado) and played back on a direct-writing oscillograph (Mark 200, Gould-Brush, Cleveland, Ohio). A Cardiotachometer (Model 9857B, Beckman Instruments, Fullerton, California) triggered by the LV pressure pulse, provided instantaneous and continuous records of heart rate. Continuous records of LV dP/dt were derived from the LV pressure signals using operational amplifiers connected as differentiators and having a frequency response of 700 Hz. A triangular wave signal was substituted for the pressure signals to directly calibrate the differentiator. LV end-diastolic dimensions were measured at the onset of LV contraction. indicated by the initial increase in LV dP/dt. LV end systole was defined as the point of maximum negative dP/dt. Ejection time was taken as the interval between maximum and minimum LV dP/dt. The derived ejection phase index, Vcf, was calculated as follows: Vcf=(EDD-ESD/EDD)/ET, where Vcf is the mean velocity of circumferential fiber shortening, EDD is the end-diastolic internal diameter, ESD is the end-systolic internal diameter, and ET is the ejection time. The analog signals of LV pressure and dimension were digitized at 2.5-msec intervals using an IBM PC/AT. The computer was used to calculate global LV systolic circumferential wall stress using a cylindrical model, stress=1.36 (PD/ 2h), where P is LV pressure, D is internal short-axis diameter, and h is wall thickness. The integral of the area under the systolic wall stress-time curve was divided by the ejection time to determine average systolic wall stress. The diastolic relaxation time constant (r) was calculated using the formula described by Weiss et al18:
P=Ae-
The radial myocardial stiffness constant was calculated from minimum LV pressure to the peak of atrial contraction using the formula developed by Mirskyl9 and used previously by Fujii et al,20 P=Ah, where P is the LV pressure, h is the wall thickness, and /8 is the radial myocardial stiffness constant. In one dog with LV failure, the diastolic portion of the wall thickness phasic waveform was inadequate for the calculation of radial myocardial stiffness. The LV end-diastolic stress-dimension ratio was also used as an index of LV chamber stiffness.2'
Statistical Analysis
Statistical analysis was performed using an IBM AT computer. The data are reported as mean+SEM. The effects of isoproterenol infusion on the measured variables were assessed for statistical significance by Student's t test for paired comparisons. Differences in the measured variables between the control group and the heart failure group were assessed for statistical significance by Student's t test for unpaired comparisons.22
Results
Effects of Left Ventricular Hypertrophy and Failure
The pathologic data are included in Table 1 . The LV weight to body weight ratio in the LV failure dogs (8.6+0.5) was significantly greater (p<0.01) than in the control dogs (5.1+0.3), whereas the body weights and RV weight to body weight ratio were similar in both groups.
Baseline data for LV systolic function are included in Table 2 , whereas baseline data for LV diastolic function are included in Table 3 . In the dogs with LV hypertrophy and failure, LV systolic pressure and wall stress were greater (p<0.01), whereas the baseline mean arterial pressure was less (p<O.O5) than that observed in the control dogs. In the dogs with LV failure, there was a baseline peak-to-peak LV to aortic systolic gradient of 187±18 mm Hg. The baseline heart rate in the LV failure dogs was also greater (p<0.01) than that in the control animals. Baseline rate of change of LV short-axis diameter (LV dD/dt) was depressed (p <0.05) in the dogs with LV failure. There were also major differences in baseline indexes of LV diastolic function. LV end-diastolic pressure and LV end-diastolic wall stress and LV end-diastolic stress-dimensions ratio were greater (p<0.01) in the LV failure group than in the normal group (Table 3 ). Diastolic radial myocardial stiffness was increased, but not significantly, whereas the time constant of isovolumic relaxation was similar in both groups.
Effects of Isoproterenol
An example of the effects of isoproterenol (0.4 pug/kg/min) is compared in a control dog and in a dog with LV failure in Figure 1 . The effects of graded doses of isoproterenol are shown in Figures  2 and 3 . The average data for the 0.4-,ug/kg/min dose of isoproterenol for all dogs studied are included Dose of Isoproterenol (,ug/kg/min) FIGURE 2. Bar graphs of responses of LV systolic wall stress (upper panel) and end-diastolic stress (lower panel) are shown to graded infusions of isoproterenol. At baseline, LVsystolic and end-diastolic stresses were greater (p<0. 01) in the LVfailure dogs than in the control dogs. During isoproterenol infusions in the control dogs, LV end-diastolic stress decreased, and LVsystolic wall stress did not change. In the dogs with LVfailure, LVsystolic stress rose with isoproterenol, whereas LV end-diastolic stress tended to fall at the lower doses, but rose with the higher doses of isoproterenol. LV, left ventricular. isoproterenol infusion. The LV end-diastolic internal diameter did not change in the dogs with LV failure but decreased (p <0.01) in the control group. LV end-systolic diameter decreased in both groups, but the magnitude of decrease was greater (p<0.01) in the control dogs than in the LV failure dogs. During isoproterenol infusion, LV end-diastolic wall thickness did not change significantly in the dogs with LV failure, but it increased (p<0.01) in the control dogs. LV end-systolic wall thickness increased (p<0.01) in both groups, but the magnitude of increase was greater in the control group than in the LV failure group. LV systolic wall stress increased (p<0.01) by 61±5 g/cm2 in the LV failure dogs, but it did not change significantly in the control dogs. In both groups, Vcf and LV dD/dt increased with isoproterenol, but the magnitude of increase was significantly greater (p<0.01) in the control dogs. Figure 4 illustrates the relationship between the LV ejection phase indexes (Vcf, dD/dt) and the average LV systolic wall stress to the higher doses of isoproterenol. In dogs with LV failure, the relationship is shifted downward and to the right, suggesting impaired systolic response to the higher doses of isoproterenol.
During isoproterenol infusion, all the diastolic indexes were depressed in the control dogs (Table  3 ). In the LV failure dogs, LV end-diastolic pressure, LV end-diastolic wall stress, and the LV end-diastolic stress-dimension ratio tended to fall at the lower doses, but when the dose of isoproterenol exceeded 0.1 jtg/kg/min, these parameters increased (p<0.05) in the LV failure dogs. Different responses of the time constant of isovolumic relaxation and the diastolic radial myocardial stiffness constant were also observed in the dogs with LV failure (Table 3 ). Figure 5 compares the diastolic portion of the LV pressure-diameter loop for a control dog and an LV failure dog. In the dog with LV failure, the diastolic relationship is shifted in response to isoproterenol so that at any given diameter, LV enddiastolic pressure is higher.
Effects of Isoproterenol on Regional Myocardial Blood Flow
The data for regional myocardial blood flow during baseline and in response to isoproterenol (0.4 gg/kg/min) are included in Table 4 . Endocardial blood flow increased to the same level in both groups, but the magnitude of increase was less in the LV failure group (0.90±+0.18 ml/min/g) compared with control group (1.39±0.26 ml/min/g). Dur- ing isoproterenol infusion, the endocardial to epicardial blood flow ratio decreased (p<0.05) in the LV failure dogs to 0.59±0.06 compared with 0.93+±0.06 in the control dogs. Although mean arterial pressure fell with isoproterenol in the dogs with LV failure, mean coronary perfusion pressure actually increased, suggesting that alterations in perfu-CONTROL 50T sion pressure cannot account for the relative subendocardial hypoperfusion. Diastolic aortic pressure fell similarly in both groups.
Hemorrhage and Volume Load
To determine whether or not the differences in response of the relaxation and stiffness constants in the control dogs and in the dogs with LV failure in response to isoproterenol infusion were secondary to directionally different effects on preload, the effects of hemorrhage and volume load were examined in four control dogs. In these experiments, LV end-diastolic pressure was varied by approximately ±5 mm Hg from the baseline values. These changes were selected to simulate the changes in LV enddiastolic pressure that were observed in the control dogs and in the LV failure dogs with isoproterenol (0.4 ,g/kg/min). In control dogs, both decreasing LV end-diastolic pressure by 4.7±0.5 mm Hg and increasing LV end-diastolic pressure by 4.4±0.6 mm Hg, failed to alter the relaxation or stiffness constants significantly (Table 5) .
Differences Between Pressure Overload Left Ventricular Failure and Pressure Plus Volume Overload Left Ventricular Failure
Hemodynamics at baseline and in response to isoproterenol are compared in the five dogs with pressure overload LV hypertrophy and failure and in the five dogs in which an arteriovenous shunt was applied to existing pressure overload LV hypertrophy (Table 6 ). Although LV systolic stress tended to be greater in the dogs with combined pressure and volume overload, the remaining measurements were similar in both groups, indicating that there were no major differences in hemodynamic response in these two models. 
Discussion
In this study, aortic banding in puppies induced equivalent LV hypertrophy to that observed in previous studies from this laboratory1ll2'20'23 and other laboratories24-27 using a similar model. However, in contrast to most prior studies in which compensated LV hypertrophy was examined,2023 LV failure occurred in the present investigation. LV failure was characterized by increases in heart rate, LV end-diastolic pressure, LV end-diastolic and LV systolic wall stress, and by decreases in mean arterial pressure, LV Vcf, LV dD/dt, and percentage of wall thickening compared with the control dogs. The role of inotropic therapy in general and of f3-adrenergic receptor stimulation in particular remains controversial in heart failure.
Our results indicate that the hypertrophied and failing LV does not have sufficient functional reserve to accommodate the acute inotropic and chronotropic stress of isoproterenol. The stress of isoproterenol further impaired both systolic and diastolic LV function, particularly when the dose exceeded 0.1 ,ug/kg/min. Isoproterenol increased LV enddiastolic pressure, both LV end-diastolic and LV systolic wall stresses, and myocardial and LV cham-ber stiffness. The LV relaxation time constant, which is known to fall in response to catecholamines in the normal heart28'29 and which did so in the control dogs, fell significantly less in the dogs with LV hypertrophy and failure. To exclude the possibility that the changes in LV end-diastolic pressure alone were responsible for the alterations in the relaxation constant and stiffness constant, experiments were carried out in normal dogs with volume loading and volume depletion. In these experiments, alterations in LV end-diastolic pressure over the same range observed with isoproterenol failed to alter either the relaxation or stiffness constant, thus negating this possibility.
The results from prior studies on effects of 1Badrenergic receptor agonists in LV hypertrophy and failure have shown both normal and depressed inotropic responses.5-7,30-32 However, most of the prior work in experimental animals was either conducted in a state of compensated pressure overload LV hypertrophy,23,30,33 or used anesthetized or in vitro preparations.7'30-32 Prior studies from our laboratory found normal inotropic responses to ,Badrenergic receptor stimulation using sympathomimetic amines in conscious chronically instrumented animals with compensated pressure overload LV hypertrophy. 23, 33 In contrast, in the present investigation, conscious animals with LV failure could not respond appropriately to the combined inotropic and chronotropic stimulation induced by isoproterenol. One mechanism to explain the impaired response of the failing LV to the infusion of isoproterenol is the chronotropic effect of the drug. A recent study from this laboratory showed that in conscious, chronically instrumented dogs with compensated LV hypertrophy, atrial pacing induced systolic and diastolic dysfunction.20 In that prior study, the threshold for systolic and diastolic dysfunction was between 210 and 240 beats/min, which corresponded to an increase of over 100% from the baseline heart rate. In the LV failure dogs in the present study, systolic and diastolic dysfunction appeared when isoproterenol increased heart rate over 164 beats/min, which corresponded to an increase of less than 20% from baseline. Thus, in contrast to the model of compensated LV hypertrophy, the failing heart may be more susceptible to the deleterious effects of increasing heart rate. Alternatively, the inotropic stress coupled with the chronotropic stress in the presence of limited coronary flow reserve resulted in systolic and diastolic decompensation.
There are considerable data supporting the hypothesis that impairment of myocardial perfusion results in relative myocardial ischemia and LV dysfunction in the presence of pressure overload LV hypertrophy. This pathologic state is characterized by reduced coronary reserve in response to maximal vasodilation induced by either adenosine or reactive hyperemia. 24, 27 The reduced coronary reserve is most evident in the subendocardium, particularly in the presence of LV failure. 34 With the stress of exercise, which increases sympathetic tone, heart failure can be induced or intensified, potentially due to severe limitations in coronary reserve. 35 In dogs with stable LV hypertrophy, exercise is associated with subendocardial hypoperfusion36 and evidence of subendocardial mechanical dysfunction (unpublished data).
In the present investigation, the inotropic and chronotropic actions of isoproterenol induced greater increases in LV systolic and diastolic stress in the dogs with LV failure than were observed in control dogs. Thus, the same dose of isoproterenol increased myocardial metabolic demands more in the dogs with LV failure and should have increased myocardial blood flow to a greater extent. Indeed, this is what was observed in the subepicardium. However, the rise in subendocardial blood flow was limited in the dogs with LV failure, with a resultant decline in the endocardial to epicardial blood flow ratio. The impairment in subendocardial flow cannot be attributed to reduced perfusion pressure because mean coronary perfusion pressure rose with isoproterenol in the dogs with LV failure, and end-diastolic aortic pressure fell similarly in control dogs and dogs with LV failure in response to isoproterenol. The findings of impaired systolic and diastolic function in association with subendocardial hypoperfusion in dogs with LV failure exposed to the ,3-adrenergic agonist, isoproterenol, are in contradistinction to the recent observations in humans with hypertrophic cardiomyopathy.37 In that study, intravenous infusions of isoproterenol sufficient to increase the heart rate to 130-150 beats/min were associated with a facilitation of diastolic relaxation. 37 The authors suggest that this improvement occurred despite circumstantial evidence of myocardial ischemia suggested by coronary lactate production. In the present study, impaired systolic and diastolic function were most evident at the higher doses of isoproterenol, where the inotropic and chronotropic effects were more substantial than those used in prior studies in humans. In fact, at the lower doses of isoproterenol in the current study, LV end-diastolic stress fell in dogs with LV failure (Figure 2) .
A recent study from our laboratory34 has shown that, in the hypertrophied LV with failure, the impairment of subendocardial coronary reserve was even more pronounced than previously shown in compensated LV hypertrophy24,38,39 and was associated with an increase in fibrosis in the endocardial layers. In that study, as well as the present study, subepicardial flow was preserved. However, both increased subendocardial fibrosis and the relative subendocardial ischemia may contribute to the impaired diastolic function observed in the current investigation with isoproterenol. In this connection, myocardial ischemia has been well documented to result not only in systolic dysfunction but also in diastolic dysfunction.18,40-42 Accordingly, the relative underperfusion of the subendocardium could have been the mechanism responsible for the systolic and diastolic dysfunction observed with isoproterenol in the dogs with LV failure.
Conceivably, the elevated end-diastolic stress at baseline and in response to isoproterenol in dogs with LV failure contributes in part to the reduction in subendocardial perfusion observed in the present study because this mechanism would increase extravascular compression of coronary vessels during diastole, when the major fraction of coronary blood flow occurs. However, this mechanism alone could not account for the observed impairment in diastolic function with isoproterenol because the experiments with volume loading also increased LV end-diastolic stress but were not associated with a decline in indexes of diastolic function ( Table 5 ).
In conclusion, the present investigation shows that in conscious dogs with LV failure secondary to pressure overload LV hypertrophy, the sympathomimetic amine, isoproterenol, further impaired systolic and diastolic LV function. This was associated with a marked decline in the endocardial to epicardial blood flow ratio, suggesting relative subendocardial ischemia. Thus, although LV failure is associated with alterations in 13-adrenergic receptor density'0 and in the GTP regulatory protein, G ,11"12 these mechanisms may not be solely responsible for the attenuated responses of LV function to potent ,3-adrenergic agonists. In the presence of pressure overload LV hypertrophy and failure, relative subendocardial ischemia must also be considered. This mechanism may contribute to the depressed systolic function and impaired diastolic function observed in response to potent sympathomimetic amines in this model of LV hypertrophy and failure. It remains to be determined whether a similar mechanism operates in models of LV failure not associated with pressure overload LV hypertrophy.
